Loss of A, B, and H antigens in oral cancer

Hakomori, 1989, Aberrant glycosylation in tumor and tumor associated carbohydrate antigens, Adv Can Res, 52, 257, 10.1016/S0065-230X(08)60215-8 Clausen, 1994, Molecular genetics of ABO, Vox Sang, 78, 91 Bianco, 2001, Loss of red cell A, B, and H antigens is frequent in myeloid malignancies, Blood, 97, 3633, 10.1182/blood.V97.11.3633 Hakomori, 1999, Antigen structure and genetic basis of histo-blood groups A, B and O: Their changes associated with human cancer, Biochim Biophys Acta, 1473, 247, 10.1016/S0304-4165(99)00183-X Hakomori, 2002, Glycosphingolipid-dependent cross-talk between glycosynapses interfacing tumor cells with their host cells: Essential basis to define tumor malignancy, FEBS Letters, 531, 88, 10.1016/S0014-5793(02)03479-8 Le Pendu, 2001, ABH and Lewis histo-blood group antigens in cancer, Acta Pathol Microbiol Immunol Scand, 109, 9, 10.1111/j.1600-0463.2001.tb00011.x Gao, 2004, Genetic and epigenetic alterations of the blood group ABO gene in oral squamous cell carcinoma, Int J Cancer, 109, 230, 10.1002/ijc.11592 Hakomori, 2002, Glycosphingolipid-dependent cross-talk between glycosynapses interfacing tumor cells with their host cells: essential basis to define tumor malignancy, FEBS Letters, 531, 88, 10.1016/S0014-5793(02)03479-8 Walkers, 2002, American Association of Blood Banks. Manual técnico. 13th ed. Buenos Aires., Asociación Argentina de Hemoterapia e Inmunohematología. Strauchen, 1998, Expression of A and B Tissue Isoantigens in benign and malignant lesions of the Breast, Cancer, 45, 2149, 10.1002/1097-0142(19800415)45:8<2149::AID-CNCR2820450823>3.0.CO;2-7 Ravn, 2000, Tissue distribution of histo-blood group antigens, Acta Pathol Microbiol Immunol Scand, 108, 1, 10.1034/j.1600-0463.2000.d01-1.x Hakomori, 1999, Antigen structure and genetic basis of histo-blood groups A, B and O: their changes associated with human cancer, Biochim Biophys Acta, 1473, 247, 10.1016/S0304-4165(99)00183-X Solís, 1997, Comparative study of the ABH antigenic expression between urothelium and buccal desquamation cells in patients with bladder carcinoma, Acta Urol Itál, 11, 187 Foresto, 2000, Glicosilación anormal de antígenos ABH solubles en patologías tumorales del tracto urinario, Arch Esp Urol, 53, 196 Boileau, 1985, Comparison of specific red-cell adherence and immunoperoxidase staining techniques for ABO(H) blood-group cell-surface antigens on superficial transitional cell carcinoma of the bladder, J Surg Oncol, 30, 72, 10.1002/jso.2930300203 Gao, 2004, Histo-blood group ABO antigen in oral potentially malignant lesions and squamous cell carcinoma: Genotypic and phenotypic characterization, Acta Pathol Microbiol Immunol Scand, 112, 11, 10.1111/j.1600-0463.2004.apm1120103.x Gao, 2004, Genetic and epigenetic alterations of the blood group ABO gene in oral squamous cell carcinoma, Int J Cancer, 109, 230, 10.1002/ijc.11592 Santos-Garcia, 2006, E-cadherin, laminin and collagen IV expression in the evolution from dysplasia to oral squamous cell carcinoma, Med Oral Patol Oral Cir Bucal, 11, E100 Ravn, 2000, Tissue distribution of histo-blood group antigens, Acta Pathol Microbiol Immunol Scand, 108, 1, 10.1034/j.1600-0463.2000.d01-1.x Dabelsteen, 1975, Loss of epithelial blood group antigens A and B in oral premalignant lesions, Acta Pathol Microbiol Scand (A), 83, 292 Campi, 2007, Secretor status and ABH antigens expression in patients with oral lesions, Med Oral Patol Oral Cir Bucal, 12, E431